Radiotherapy and chemoradiation after surgery for early cervical cancer

Cochrane Database of Systematic Reviews

Volumn 2012, Issue 5, 2012, Pages

  Rogers, Linda ^a   Siu, Shing Shun N ^b   Luesley, David ^c   Bryant, Andrew ^d   Dickinson, Heather O ^d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c CITY HOSPITAL   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT RADIOTHERAPY; CANCER ADJUVANT THERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CERVICECTOMY; CHEMORADIOTHERAPY; COMPARATIVE EFFECTIVENESS; CONFIDENCE INTERVAL; CONSTIPATION; DIARRHEA; DISEASE EXACERBATION; EVIDENCE BASED PRACTICE; HEMATOLOGIC DISEASE; HISTOLOGY; HUMAN; HYDRONEPHROSIS; INTERMETHOD COMPARISON; INTESTINE OBSTRUCTION; LEG SWELLING; LOW RISK POPULATION; LYMPH NODE DISSECTION; OVERALL SURVIVAL; PELVIS LYMPH NODE; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAFETY; SCAR FORMATION; SEXUAL DYSFUNCTION; SYSTEMATIC REVIEW; URETER OBSTRUCTION; URINARY FREQUENCY; UTERINE CERVIX CANCER; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; FEMALE; HYSTERECTOMY; META ANALYSIS; METHODOLOGY; MORTALITY; PATHOLOGY; TUMOR RECURRENCE; UTERINE CERVIX TUMOR;

CHEMORADIOTHERAPY, ADJUVANT; FEMALE; HUMANS; HYSTERECTOMY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UTERINE CERVICAL NEOPLASMS;

EID: 84864515154     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007583.pub3     Document Type: Review

References (25)

1. Bilek K, Ebeling K, Leitsmann H, Seidel G. Radical pelvic surgery versus radical surgery plus radiotherapy for stage IB carcinoma of the cervix uteri: preliminary results of a prospective randomised clinical study. Archiv fur Geschwulstforschung 1982;52(3):223-29.
2. Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI, et al.A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a gynaecologic oncology group study. International Journal of Radiation Oncology and Biological Physics 2006;65(1):169-76.
3. Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study. Gynecologic Oncology 1999;73:177-83.
4. Lahousen M, Haas J, Pickel H, Hackl A, Kurz C, Ogris H, et al.Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: a randomized, prospective, multicenter trial. Gynecologic Oncology 1999;73:196-201.
5. Benedet JL, Hacker NF, Ngan HYS. Staging classifications and clinical practice guidelines of gynaecologic cancers by FIGO Committee on Gynecologic Oncology and IGCS Guidelines Committee. International Journal of Gynaecology and Obstetrics 2000;70:207-312.
6. Vale C, Tierney JF, Stewart LA, Brady M, Dinshaw K, Jakobsen A, et al (CCCMAC). Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis (Review). Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD008285;: ]
7. National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE). http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_30 (accessed 15 March 2012).
8. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. Egger M, Davey Smith G, Altman DG (editors). Systematic Reviews in Health Care: Meta-Analysis in Context (2nd edition). London: BMJ Publication Group, 2001:313-35.
9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
10. Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, et al and the EUROCARE Working Group. EUROCARE-3: survival of cancer patients diagnosed 1990-94 - results and commentary. Annals of Oncology 2003;14(Suppl 5):v61-v118.
11. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008. Cancer Incidence and Mortality Worldwide. IARC CancerBase No. 10, version 2.0. IARC Press, Lyon, France, 2010. Available from http://globocan.iarc.fr.
12. Gray HJ. Primary management of early stage cervical cancer (IA1-IB) and appropriate selection of adjuvant therapy. Journal of the National Comprehensive Cancer Network 2008;6(1):47-52.
13. Guttmann R. Significance of post-operative irradiation in carcinoma of the cervix: a ten year survey. American Journal of Roentgenology 1970;108:102-8.
14. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
15. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
16. Kesic V. Management of cervical cancer. European Journal of Surgical Oncology 2006;32(8):832-7.
17. Kitchener HC, Hoskins W, Small, W, Thomas GM, Trimble EL and the Cervical Cancer Consensus Group. The development of priority cervical cancer trials: a Gynecologic Cancer InterGroup report. International Journal of Gynecological Cancer 2010;20:1092-1100.
18. Moher D, Pham D, Jones A, Cook DJ, Jadad AR, Moher M. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352:609-13.
19. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
20. Peters WA, Liu PY, Barrett RJ, Stock RJ, Monk BJ, Berek JS. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. Journal of Clinical Oncology 2000;18(8):1606-13.
21. Rosa DD, Medeiros LR, Bozzetti MC, Edelweiss MI, Pohlmann PR, Stein AT. Adjuvant chemotherapy for early stage cervix cancer. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD008285;: ]
22. Rydzewska L, Tierney J, Vale CL, Symonds PR. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD007406.pub2]
23. Schulz KF, Chalmers I, Hayes RJ, Altman D. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
24. Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage Ib carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecologic Oncology 1999;73(2):177-83.
25. Rogers L, Sui SSN, Luesley D, Bryant A, Dickinson HO. Adjuvant radiotherapy and chemoradiation after surgery for cervical cancer. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD007583.pub2]